{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:35:21Z","timestamp":1781609721836,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11255-021-02953-0","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T12:03:18Z","timestamp":1626696198000},"page":"873-881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Urinary citrate as a marker of renal function in patients with autosomal dominant polycystic kidney disease"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8861-3132","authenticated-orcid":false,"given":"Francisco Jos\u00e9","family":"Borrego Utiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidoro","family":"Herrera Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enoc","family":"Merino Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Victoria","family":"Camacho Reina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Moriana Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oca\u00f1a P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"2953_CR1","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ki.1990.265","volume":"38","author":"LL Hamm","year":"1990","unstructured":"Hamm LL (1990) Renal handling of citrate. Kidney Int 38:728\u2013735","journal-title":"Kidney Int"},{"key":"2953_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0025-7125(16)32009-0","volume":"59","author":"SB Baruch","year":"1975","unstructured":"Baruch SB, Burich RL, Eun CK, King VF (1975) Renal metabolism of citrate. Med Clin North Am 59:569\u2013582","journal-title":"Med Clin North Am"},{"key":"2953_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000080259","volume":"98","author":"RJ Unwin","year":"2004","unstructured":"Unwin RJ, Capasso G, Shirley DG (2004) An overview of divalent cation and citrate handling by the kidney. Nephrol Physiol 98:15\u201320","journal-title":"Nephrol Physiol"},{"issue":"3","key":"2953_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00240-014-0653-4","volume":"42","author":"KS Hering-Smith","year":"2014","unstructured":"Hering-Smith KS, Mao W, Schiro FR, Coleman-Barnett J, Pajor AM, Hamm LL (2014) Localization of the calcium regulated citrate transport process in proximal tubule cells. Urolithiasis 42(3):209\u20132019","journal-title":"Urolithiasis"},{"key":"2953_CR5","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2215\/CJN.03100608","volume":"4","author":"JL Nishiura","year":"2009","unstructured":"Nishiura JL, Neves RFCA, Eloi SRM, Cintra SMLF, Ajzen SA, Heilberg IP (2009) Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 4:838\u2013844","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2953_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0272-6386(12)80922-X","volume":"22","author":"VE Torres","year":"1993","unstructured":"Torres VE, Wilson DM, Hattery RR, Segura JW (1993) Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 22(4):513\u2013519","journal-title":"Am J Kidney Dis"},{"key":"2953_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2214\/ajr.159.1.1609726","volume":"159","author":"E Levine","year":"1992","unstructured":"Levine E, Grantham JJ (1992) Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients. AJR Am J Roentgenol 159:77\u201381","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"2953_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0272-6386(88)80137-9","volume":"11","author":"VE Torres","year":"1988","unstructured":"Torres VE, Erickson SB, Smith LH, Wilson DM, Hattery RR, Segura JW (1988) The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis 11(4):318\u2013325","journal-title":"Am J Kidney Dis"},{"key":"2953_CR9","first-page":"F63","volume":"272","author":"MR Ogborn","year":"1997","unstructured":"Ogborn MR, Sareen S, Prychitko J, Buist R, Peeling J (1997) Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: an NMR study. Am J Physiol 272:F63\u2013F69","journal-title":"Am J Physiol"},{"key":"2953_CR10","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1038\/ki.1994.227","volume":"45","author":"VE Torres","year":"1994","unstructured":"Torres VE, Keith DS, Offord KP, Kon SP, Wilson DM (1994) Renal ammonia in autosomal dominant polycystic kidney disease. Kidney Int 45:1745\u20131753","journal-title":"Kidney Int"},{"issue":"5","key":"2953_CR11","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.kint.2018.11.033","volume":"95","author":"N Goraya","year":"2019","unstructured":"Goraya N, Simoni J, Sager LN, Madias NE, Wesson DE (2019) Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis. Kidney Int 95(5):1190\u20131196","journal-title":"Kidney Int"},{"issue":"2","key":"2953_CR12","doi-asserted-by":"publisher","first-page":"F502","DOI":"10.1152\/ajprenal.00044.2019","volume":"317","author":"N Goraya","year":"2019","unstructured":"Goraya N, Simoni J, Sager LN, Mamun A, Madias NE, Wesson DE (2019) Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease. Am J Physiol Renal Physiol 317(2):F502\u2013F511","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"2953_CR13","doi-asserted-by":"publisher","first-page":"F985","DOI":"10.1152\/ajprenal.00463.2017","volume":"314","author":"N Goraya","year":"2018","unstructured":"Goraya N, Simoni J, Sager LN, Pruszynski J, Wesson DE (2018) Acid retention in chronic kidney disease is inversely related to GFR. Am J Physiol Renal Physiol 314(5):F985\u2013F991","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"2953_CR14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.kint.2019.01.019","volume":"95","author":"C Prot-Bertoye","year":"2019","unstructured":"Prot-Bertoye C, Vallet M, Houillier P (2019) Urinary citrate: helpful to predict acid retention in CKD patients? Kidney Int 95(5):1020\u20131022","journal-title":"Kidney Int"},{"key":"2953_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaa142.P0234","author":"FJ Borrego Utiel","year":"2020","unstructured":"Borrego Utiel FJ, Merino GE, Herrera I, Moriana C, Camacho V, Oca\u00f1a E, Garc\u00eda Cort\u00e9s MJ (2020) Low urinary citrate levels are not specific of autosomal polycystic kidney disease (ADPKD) and are present when renal function is impaired in all nephropaties. Nephrol Dial Transpl. https:\/\/doi.org\/10.1093\/ndt\/gfaa142.P0234","journal-title":"Nephrol Dial Transpl"},{"key":"2953_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1681\/ASN.2008050507","volume":"20","author":"Y Pei","year":"2009","unstructured":"Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, SanMillan JL, Gibson R, Breuning M, Peters D, Ravine D (2009) Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 20:205\u2013212","journal-title":"J Am Soc Nephrol"},{"key":"2953_CR17","doi-asserted-by":"crossref","unstructured":"Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC, Conference Participants (2015) Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 88(1):17\u201327","DOI":"10.1038\/ki.2015.59"},{"issue":"3","key":"2953_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0003-2697(66)90172-2","volume":"17","author":"H Moellering","year":"1966","unstructured":"Moellering H, Gruber W (1966) Determination of citrate with citrate lyase. Anal Biochem 17(3):369\u2013376","journal-title":"Anal Biochem"},{"key":"2953_CR19","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2953_CR20","doi-asserted-by":"publisher","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP; STROBE Initiative (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370(9596):1453\u20131457. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X (PMID: 18064739)","DOI":"10.1016\/S0140-6736(07)61602-X"},{"issue":"1","key":"2953_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1681\/ASN.2013101138","volume":"26","author":"MV Irazabal","year":"2015","unstructured":"Irazabal MV, Rangel LJ, Bergstralh EJ, Osborn SL, Harmon AJ, Sundsbak JL, Bae KT, Chapman AB, Grantham JJ et al (2015) Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol 26(1):160\u2013172","journal-title":"J Am Soc Nephrol"},{"key":"2953_CR22","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13411","author":"M Perinpam","year":"2017","unstructured":"Perinpam M, Ware EB, Smith JA, Turner ST, Kardia SLR, Lieske JC (2017) Association of urinary citrate excretion, pH, and net gastrointestinal alkali absorption with diet, diuretic use, and blood glucose concentration. Physiol Rep. https:\/\/doi.org\/10.14814\/phy2.13411","journal-title":"Physiol Rep"},{"issue":"1","key":"2953_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.urology.2011.12.019","volume":"80","author":"B Gershman","year":"2012","unstructured":"Gershman B, Sheth S, Dretler SP et al (2012) Relationship between glomerular filtration rate and 24-hour urine composition in patients with nephrolithiasis. Urology 80(1):38\u201342","journal-title":"Urology"},{"key":"2953_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/bcp.12751","volume":"81","author":"RA Jhagroo","year":"2015","unstructured":"Jhagroo RA, Wertheim ML, Penniston KL (2015) Alkali replacement raises urinary citrate excretion in patients with topiramate-induced hypocitraturia. Br J Clin Pharmacol 81:131\u2013136","journal-title":"Br J Clin Pharmacol"},{"key":"2953_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1210\/jc.2017-01778","volume":"103","author":"MK Shea","year":"2018","unstructured":"Shea MK, Dawson-Hugues B (2018) Association of urinary citrate with acid-base status, bone resorption, and calcium excretio in older men and women. J Clin Endocrinol Metab 103:452\u2013459","journal-title":"J Clin Endocrinol Metab"},{"key":"2953_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1053\/ajkd.2000.8266","volume":"36","author":"SA Grampsas","year":"2000","unstructured":"Grampsas SA, Chandhoke PS, Fan J et al (2000) Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 36:53\u201357","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2953_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.kint.2020.07.006","volume":"99","author":"FG Gianella","year":"2021","unstructured":"Gianella FG, Prado VE, Poindexter JR, Adams-Huet B, Li X, Miller RT, Sakhaee K, Maalouf NM, Moe OW (2021) Spot urinary citrate-to-creatinine ratio is a marker for acid-base status in chronic kidney disease. Kidney Int 99(1):208\u2013217","journal-title":"Kidney Int"},{"key":"2953_CR28","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1681\/ASN.V971242","volume":"9","author":"GA Tanner","year":"1998","unstructured":"Tanner GA (1998) Potassium citrate\/citric acid intake improves renal function in rats with polycystic kidney disease. J Am Soc Nephrol 9:1242\u20131248","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2953_CR29","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2215\/CJN.13091118","volume":"14","author":"SD Navaneethan","year":"2019","unstructured":"Navaneethan SD, Shao J, Buysse J, Bushinsky DA (2019) Effects of treatment of metabolic acidosis in CKD: a systematic review and meta-analysis. Clin J Am Soc Nephrol 14(7):1011\u20131020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2953_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/MNH.0000000000000491","volume":"28","author":"N Goraya","year":"2019","unstructured":"Goraya N, Wesson DE (2019) Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease. Curr Opin Nephrol Hypertens 28(3):267\u2013277","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"2953_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/00365599209181230","volume":"26","author":"A Trinchieri","year":"1992","unstructured":"Trinchieri A, Mandressi A, Luongo P, Rovera F, Longo G (1992) Urinary excretion of citrate, glycosaminoglycans, magnesium and zinc in relation to age and sex in normal subjects and in patients who form calcium stones. Scand J Urol Nephrol 26(4):379\u2013386","journal-title":"Scand J Urol Nephrol"},{"issue":"2","key":"2953_CR32","doi-asserted-by":"publisher","first-page":"F425","DOI":"10.1152\/ajprenal.00036.2010","volume":"300","author":"KS Hering-Smith","year":"2011","unstructured":"Hering-Smith KS, Schiro FR, Pajor AM, Hamm LL (2011) Calcium sensitivity of dicarboxylate transport in cultured proximal tubule cells. Am J Physiol Renal Physiol 300(2):F425\u2013F432","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"2953_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00240-018-1035-0","volume":"46","author":"WR Walker","year":"2018","unstructured":"Walker WR, Zhang Sh, Coleman-Barnett Joycelynn A, Hamm LL, Hering-Smith KS (2018) Calcium receptor signaling and citrate transport. Urolithiasis 46(5):409\u2013418","journal-title":"Urolithiasis"},{"issue":"10","key":"2953_CR34","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/jbmr.3480","volume":"33","author":"RI Gafni","year":"2018","unstructured":"Gafni RI, Langman CB, Guthrie LC, Brillante BA, James R, Yovetich NA, Boyce AM, Collins MT (2018) Hypocitraturia is an untoward side effect of synthetic human parathyroid hormone (hPTH) 1\u201334 therapy in hipoparathyroidism that may increase renal morbidity. J Bone Miner Res 33(10):1741\u20131747","journal-title":"J Bone Miner Res"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-02953-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-021-02953-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-021-02953-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T12:21:03Z","timestamp":1647346863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-021-02953-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2953"],"URL":"https:\/\/doi.org\/10.1007\/s11255-021-02953-0","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,19]]},"assertion":[{"value":"6 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors have not conflict of interest to declare. We have not received any financial support for this research. We declare that the results presented in this paper have not been published previously in whole or part, except in abstract format.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}